Literature DB >> 28287731

Positional Scanning Identifies the Molecular Determinants of a High Affinity Multi-Leucine Inhibitor for Furin and PACE4.

Izabela Małuch1, Christine Levesque2,3, Anna Kwiatkowska2,3, Frédéric Couture2,3, Kévin Ly2,3, Roxane Desjardins2,3, Witold A Neugebauer2, Adam Prahl1, Robert Day2,3.   

Abstract

The proprotein convertase family of enzymes includes seven endoproteases with significant redundancy in their cleavage activity. We previously described the peptide Ac-LLLLRVK-Amba that displays potent inhibitory effects on both PACE4 and prostate cancer cell lines proliferation. Herein, the molecular determinants for PACE4 and furin inhibition were investigated by positional scanning using peptide libraries that substituted its leucine core with each natural amino acid. We determined that the incorporation of basic amino acids led to analogues with improved inhibitory potency toward both enzymes, whereas negatively charged residues significantly reduced it. All the remaining amino acids were in general well tolerated, with the exemption of the P6 position. However, not all of the potent PACE4 inhibitors displayed antiproliferative activity. The best analogues were obtained by the incorporation of the Ile residue at the P5 and P6 positions. These substitutions led to inhibitors with increased PACE4 selectivity and potent antiproliferative effects.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28287731     DOI: 10.1021/acs.jmedchem.6b01499

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Design and Structure-Activity Relationship of a Potent Furin Inhibitor Derived from Influenza Hemagglutinin.

Authors:  Monika A Lewandowska-Goch; Anna Kwiatkowska; Teresa Łepek; Kévin Ly; Pauline Navals; Hugo Gagnon; Yves L Dory; Adam Prahl; Robert Day
Journal:  ACS Med Chem Lett       Date:  2021-02-05       Impact factor: 4.345

2.  Current Challenges and Opportunities in Treating Glioblastoma.

Authors:  Andrea Shergalis; Armand Bankhead; Urarika Luesakul; Nongnuj Muangsin; Nouri Neamati
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

3.  Enhanced anti-tumor activity of the Multi-Leu peptide PACE4 inhibitor transformed into an albumin-bound tumor-targeting prodrug.

Authors:  Anna Kwiatkowska; Frédéric Couture; Samia Ait-Mohand; Roxane Desjardins; Yves L Dory; Brigitte Guérin; Robert Day
Journal:  Sci Rep       Date:  2019-02-14       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.